Recently, I met with a patient who was diagnosed with localized prostate cancer at a local urology office. He came to Swedish seeking a second opinion for the treatment of his prostate cancer. In doing this, he explained to me that after the diagnosis of his prostate cancer, he was referred to a website to review the available options for the management of prostate cancer and was given very little guidance by the urologist who made the diagnosis. Unfortunately, this is a common scenario in situations where the diagnosing urologist may not have all of the available treatment options at his or her disposal. In discussing this with him afterwards, he felt that the urologist was only interested in making a diagnosis but had no concern over his treatment choice and he felt very confused.
The patient and I sat down together in a 45 minute consultation visit to discuss his diagnosis. As I do with all of my patients recently diagnosed with prostate cancer, we covered the diagnosis, the available treatment options, and the relative risks of each so that he could make an informed decision. I feel fortunate to practice in a place that offers state-of-the-art therapy for prostate cancer by multiple modalities. At Swedish, we have ....
On September 12, 2012, the Food and Drug Administration (FDA) approved teriflunomide for the treatment of multiple sclerosis (MS). Teriflunomide (AUBAGIO) is a once-daily pill for the treatment of relapsing forms of MS. Led by Dr. Lily Jung Henson, the Swedish Neuroscience Institute was among several clinical sites that tested the drug. Results of the research showed that teriflunomide can lessen MS disease activity. Specifically, it behaves similarly to injectable therapies by slowing MS relapse frequency, the rate of disability and MRI activity.
The safety profile, however, is more challenging than ....
If you haven’t seen it yet, check out our new web site, www.seriouslykickingcancersbutt.com.
Since opening the first cancer-radiation treatment center west of the Mississippi more than 80 years ago, Swedish has helped more people fight cancer than any other provider in the region. Even today, we are committed to ensuring that our local community has access to the most advanced tools and treatments, and the nation's leading experts in cancer care. Click here to learn more about the Swedish Cancer Institute.
Also, read other blog posts by physicians, nurses, and staff from the Swedish Cancer Institute:
Genetic Counseling – what it means for cancer patients and their families
GERD and Esophageal cancer – why you should talk with your physician about GERD
If you were diagnosed with cancer or another disease, wouldn’t you want your treatment and medicines to be as unique as you are?
This is a growing trend in medicine where the type of treatment a patient gets depends on their DNA.
The usual treatment for breast cancer may be surgery, followed by chemotherapy, possibly radiation and as a last resort, a clinical trial.
The I-SPY clinical trial turns that thinking upside down by actually extracting DNA from a tumor to figure out which new drug will likely work best, then giving it to the patient first, even before surgery.
"The goal of the I-SPY trial is really to develop a faster and cheaper way to develop new drugs for breast cancer . We're hoping that this is a new paradigm that will work for other kinds of cancer too," said Dr. Kaplan.
Essential tremor (ET) is the most common type of movement disorder, affecting approximately four out of 1000 people, and is significantly more common, though less recognized, than Parkinson’s disease. ET affects men and women equally and is inherited as an autosomal-dominant condition in about 60 percent of cases.
Although often referred to as benign essential tremor, it is hardly benign in patients who may not be able to write legibly, hold a glass of water or use a knife and fork. ET is primarily an action tremor of the upper extremities but may involve resting tremor of the head and neck and/or lower jaw, and also tremor of the voice. The latter may be so severe that speech becomes unintelligible.
Medication and surgical treatment options
Primidone and beta blockers are useful in reducing tremor in the early stages of ET, but as the tremor progresses, medical management often becomes less effective or side effects can prevent the use of adequate doses of medication. ET patients then are candidates for surgical or radiosurgical treatment.
The mainstay of the surgical treatment of ET is deep brain stimulation (DBS), in which an electrode is implanted in the ventral intermediate nucleus (VIM) of the thalamus. Neurosurgeons Peter Nora, M.D., and Ryder Gwinn, M.D., have been implanting DBS electrodes at Swedish Medical Center for several years. The treatment is effective, but it requires implantation of permanent hardware (wires and batteries) into the brain and chest wall. Patients who take anticoagulants or have severe cardiovascular disease are not suitable candidates for DBS. These patients, however, may be candidates for radiosurgical treatment.
A new option for difficult-to-treat patients